Ebola Vaccines Is Estimated To Witness High Growth Owing To Rapid...

added article Other

2023-12-13 10:44:35 -

Ebola Vaccines Is Estimated To Witness High Growth Owing To Rapid Increase In Research And Development Activities

The Ebola vaccine market is estimated to be valued at US$ 5.83 Bn in 2023 and is expected to exhibit a CAGR of 32% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Ebola vaccine market consists of vaccines that provide protection against Ebola virus infection. Ebola virus causes a severe hemorrhagic fever in humans...

0 Comments 0 Shares 1310 Views 0 Reviews